Barclays’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $266K | Sell |
43,087
-38,893
| -47% | -$240K | ﹤0.01% | 3531 |
|
|
2025
Q4 | $551K | Buy |
81,980
+3,515
| +4% | +$26.4K | ﹤0.01% | 3787 |
|
|
2025
Q3 | $641K | Sell |
78,465
-6,090
| -7% | -$45.5K | ﹤0.01% | 3645 |
|
|
2025
Q2 | $594K | Buy |
84,555
+21,600
| +34% | +$145K | ﹤0.01% | 3659 |
|
|
2025
Q1 | $449K | Sell |
62,955
-2,871
| -4% | -$27.1K | ﹤0.01% | 3599 |
|
|
2024
Q4 | $604K | Buy |
65,826
+10,318
| +19% | +$96.5K | ﹤0.01% | 3707 |
|
|
2024
Q3 | $538K | Buy |
55,508
+23,398
| +73% | +$246K | ﹤0.01% | 3730 |
|
|
2024
Q2 | $261K | Sell |
32,110
-5,665
| -15% | -$43.9K | ﹤0.01% | 3427 |
|
|
2024
Q1 | $305K | Sell |
37,775
-40,153
| -52% | -$284K | ﹤0.01% | 3891 |
|
|
2023
Q4 | $428K | Buy |
77,928
+28,822
| +59% | +$152K | ﹤0.01% | 3982 |
|
|
2023
Q3 | $256K | Buy |
49,106
+42,511
| +645% | +$302K | ﹤0.01% | 3179 |
|
|
2023
Q2 | $76.2K | Sell |
6,595
-7,102
| -52% | -$83.7K | ﹤0.01% | 3664 |
|
|
2023
Q1 | $171K | Buy |
13,697
+2,518
| +23% | +$48.2K | ﹤0.01% | 3883 |
|
|
2022
Q4 | $220K | Buy |
11,179
+5,172
| +86% | +$111K | ﹤0.01% | 3783 |
|
|
2022
Q3 | $146K | Sell |
6,007
-590
| -9% | -$16.3K | ﹤0.01% | 3363 |
|
|
2022
Q2 | $160K | Sell |
6,597
-9,808
| -60% | -$261K | ﹤0.01% | 3555 |
|
|
2022
Q1 | $530K | Sell |
16,405
-9,617
| -37% | -$302K | ﹤0.01% | 2863 |
|
|
2021
Q4 | $885K | Buy |
26,022
+7,013
| +37% | +$255K | ﹤0.01% | 2902 |
|
|
2021
Q3 | $819K | Buy |
19,009
+2,771
| +17% | +$170K | ﹤0.01% | 2898 |
|
|
2021
Q2 | $1.06M | Sell |
16,238
-11,396
| -41% | -$721K | ﹤0.01% | 2627 |
|
|
2021
Q1 | $1.45M | Buy |
27,634
+1,311
| +5% | +$65.4K | ﹤0.01% | 2532 |
|
|
2020
Q4 | $1.18M | Sell |
26,323
-812
| -3% | -$28K | ﹤0.01% | 2646 |
|
|
2020
Q3 | $788K | Buy |
27,135
+4,987
| +23% | +$157K | ﹤0.01% | 2891 |
|
|
2020
Q2 | $787K | Buy |
22,148
+3,826
| +21% | +$161K | ﹤0.01% | 2966 |
|
|
2020
Q1 | $947K | Sell |
18,322
-13,049
| -42% | -$627K | ﹤0.01% | 3010 |
|
|
2019
Q4 | $2.14M | Sell |
31,371
-10,943
| -26% | -$686K | ﹤0.01% | 2921 |
|
|
2019
Q3 | $2.03M | Sell |
42,314
-7,807
| -16% | -$407K | ﹤0.01% | 2847 |
|
|
2019
Q2 | $3.35M | Buy |
50,121
+34,215
| +215% | +$2.6M | ﹤0.01% | 2302 |
|
|
2019
Q1 | $1.52M | Sell |
15,906
-6,939
| -30% | -$866K | ﹤0.01% | 2908 |
|
|
2018
Q4 | $2.84M | Buy |
22,845
+9,219
| +68% | +$1.52M | ﹤0.01% | 2057 |
|
|
2018
Q3 | $3.33M | Sell |
13,626
-3,763
| -22% | -$870K | ﹤0.01% | 2273 |
|
|
2018
Q2 | $3.24M | Buy |
17,389
+8,149
| +88% | +$1.36M | ﹤0.01% | 2104 |
|
|
2018
Q1 | $1.14M | Buy |
9,240
+6,270
| +211% | +$765K | ﹤0.01% | 3053 |
|
|
2017
Q4 | $354K | Buy |
2,970
+2,512
| +548% | +$277K | ﹤0.01% | 4184 |
|
|
2017
Q3 | $44K | Sell |
458
-1,475
| -76% | -$142K | ﹤0.01% | 5417 |
|
|
2017
Q2 | $184K | Sell |
1,933
-5,635
| -74% | -$482K | ﹤0.01% | 4441 |
|
|
2017
Q1 | $588K | Sell |
7,568
-11,405
| -60% | -$790K | ﹤0.01% | 3244 |
|
|
2016
Q4 | $1.27M | Sell |
18,973
-21,799
| -53% | -$1.34M | ﹤0.01% | 2511 |
|
|
2016
Q3 | $2.44M | Sell |
40,772
-9,928
| -20% | -$553K | ﹤0.01% | 1829 |
|
|
2016
Q2 | $2.54M | Sell |
50,700
-3,400
| -6% | -$162K | ﹤0.01% | 1824 |
|
|
2016
Q1 | $2.38M | Sell |
54,100
-40,578
| -43% | -$1.45M | ﹤0.01% | 1765 |
|
|
2015
Q4 | $3.79M | Buy |
94,678
+64,396
| +213% | +$2.72M | ﹤0.01% | 1511 |
|
|
2015
Q3 | $1.45M | Buy |
30,282
+26,081
| +621% | +$1.24M | ﹤0.01% | 2395 |
|
|
2015
Q2 | $185K | Buy |
4,201
+4,045
| +2,593% | +$155K | ﹤0.01% | 4197 |
|
|
2015
Q1 | $5K | Sell |
156
-259
| -62% | -$8.36K | ﹤0.01% | 6576 |
|
|
2014
Q4 | $13K | Sell |
415
-1,759
| -81% | -$42.6K | ﹤0.01% | 6564 |
|
|
2014
Q3 | $43K | Sell |
2,174
-1,755
| -45% | -$35.6K | ﹤0.01% | 5998 |
|
|
2014
Q2 | $87K | Buy |
3,929
+3,790
| +2,727% | +$62.8K | ﹤0.01% | 5529 |
|
|
2014
Q1 | $2K | Buy |
+139
| New | +$2.47K | ﹤0.01% | 7402 |
|
Other funds holding INGN
AC
VCM
DCM
Barclays's INGN Position: Q1 2026 in Review
Barclays reduced its Inogen (INGN) stake by 47% in Q1 2026, selling an estimated $240K and leaving 43,087 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.
Barclays first reported a position in INGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.79M in Q4 2015. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.
- Barclays held 43,087 shares of Inogen worth $266K as of Q1 2026.
- Barclays sold 38,893 Inogen shares in Q1 2026, an estimated $240K.
- Inogen made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3531 holding.
- Barclays first reported a position in Inogen in Q1 2014 and has held it in 49 quarters since.
- Barclays's Inogen position peaked at $3.79M in Q4 2015.
- 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.